Trial Profile
Hull Prospective Analysis of OnabotulinumtoxinA (Botox) in the treatment of Chronic Migraine; A real-life data
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 17 Oct 2017 New trial record
- 10 Sep 2017 Results presented at the 2017 International Headache Society
- 10 Sep 2017 Results presented at the 2017 International Headache Society